Update 3:15pm: Updates shares, adds investor letter, company response. Indivior PLC (NASDAQ:INDV) soared 13% amid some ...

Indivior (GB:INDV) has released an update. Indivior has announced the purchase and cancellation of 294,320 ordinary shares as ...

Investment fund Oaktree Capital Management has urged British drugmaker Indivior to cooperate with the fund in refreshing its ...

With Indivior’s stock price in freefall over the past year, one of the company’s top investors is taking leadership to task, ...

Indivior (GB:INDV) has released an update. Deerfield Management Company has acquired a significant 5.165% stake in Indivior PLC, marking a ...

Investment fund Oaktree Capital Management has written to Indivior urging the opioid addiction treatment maker to refresh its ...

Indivior Plc has entered into a refinancing agreement that would allow it to push back the maturity on its existing term loan ...

Indivior (GB:INDV) has released an update. Indivior PLC is actively engaging with Oaktree Capital Management to explore proposals aimed at enhancing shareholder value. The Board is committed to ...

M&G Plc lowered its stake in shares of Indivior PLC (NASDAQ:INDV – Free Report) by 6.4% during the third quarter, according to the company in its most recent disclosure with the Securities and ...

Oaktree believes Indivior should not have waited for seven years after Sublocade's initial FDA approval, and more than a year after its competitor's entry into the market, before submitting its prior ...

Indivior PLC (NASDAQ / LSE: INDV) the Board of Directors (the "Board") of Indivior plc ("Indivior" or the "Company") notes the publication today of a letter from Oaktree Capital Management LP ...